SELLAS Life Sciences Announces Additional Positive Triple Negative Breast Cancer (TNBC) Subgroup Data Pharmaceutical Investing
Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan Pharmaceutical Investing
Ovid Therapeutics Plans to Move into the Phase 3 Trial Based on End-of-Phase 2 Meeting for OV101 Pharmaceutical Investing
NASA Deploys Medigus’ micro ScoutCam Miniature HD Camera During Robotic Refueling Mission Medical Device Investing
Rexahn Pharmaceuticals Streamlines Operations and Provides Update on Pipeline Life Science Investing News
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences Pharmaceutical Investing
Green Growth Brands Solidifies Nevada Market Position with Award of Seven Additional Cannabis Licenses Cannabis Investing News
BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference Biotech Investing
